INSULET CORP (PODD) Stock Price, Quote, News and Summary
NASDAQ:PODD - Nasdaq - US45784P1012 - Common Stock
PODD Quote and Key Statistics
INSULET CORP
NASDAQ:PODD (1/17/2025, 8:21:49 PM)
After market: 278.88 +3.07 (+1.11%)275.81
+2.95 (+1.08%)
PODD Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 21.22% | ||
| ROA | 13.91% | ||
| ROE | 37.65% | ||
| Debt/Equity | 1.21 |
PODD Performance and Technical Analysis
PODD Ownership and Analysts
PODD Latest News and Analysis
Discover the top S&P500 movers in Friday's pre-market session and stay informed about market dynamics.
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Top S&P500 movers in Thursday's session
Top movers analysis one hour before the close of the markets of S&P500 on 2025-01-16: top gainers and losers in today's session.
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
Which S&P500 stocks are moving on Thursday?
NASDAQ:PODD—A High-Growth Stock Gearing Up for Its Next Upward Move.
Is INSULET CORP (NASDAQ:PODD) on the Verge of a Major Breakout as a Strong Growth Stock?
Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.
About PODD
Company Profile
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 3,000 full-time employees. The company went IPO on 2007-05-15. The company is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. The company also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.
Company Info
INSULET CORP
100 Nagog Park
Acton MASSACHUSETTS 01720 US
CEO: Shacey Petrovic
Employees: 3000
Company Website: https://www.omnipod.com
Investor Relations: https://investor.insulet.com
Phone: 19786007000
PODD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 88.19 | 211.09B | ||
| ABT | ABBOTT LABORATORIES | 25.11 | 196.83B | ||
| SYK | STRYKER CORP | 32.94 | 146.17B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.81 | 145.41B | ||
| MDT | MEDTRONIC PLC | 16.78 | 112.94B | ||
| BDX | BECTON DICKINSON AND CO | 18.04 | 68.84B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.13 | 41.16B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.08 | 38.72B | ||
| RMD | RESMED INC | 28.92 | 35.20B | ||
| IDXX | IDEXX LABORATORIES INC | 38.29 | 34.33B | ||
| DXCM | DEXCOM INC | 49.64 | 32.96B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 19.55 | 24.25B |